Drug Topics

MAY 31, 2023

The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.

468

468

PharmaVoice

MAY 31, 2023

With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial-based organization.

245

245

Drug Topics

MAY 31, 2023

Pharmapod’s Incident Management reporting platform + Patient Safety Organization improves processes to enhance medication and patient safety

461

461

Pharmacy Times

MAY 31, 2023

As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

MAY 31, 2023

As lawmakers shine a light on Big Pharma tax cuts, the industry’s business moves are coming under attack from multiple angles.

130

130

Fierce Pharma

MAY 31, 2023

FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy kdunleavy Wed, 05/31/2023 - 13:02

Compounding 126

Compounding FDA 126

Fierce Healthcare

MAY 31, 2023

BJC HealthCare of St. | The two organizations are hoping to close their cross-market deal by the end of the year, potentially creating a new 28-hospital, integrated, academic health system.

Hospitals 116

Hospitals 116

Pharmacy Times

MAY 31, 2023

Radio frequency identification-enabled automation for inventory management has only achieved its massive adoption in the retail space over the past 2 decades.

Hospitals 123

Hospitals 123

Fierce Healthcare

MAY 31, 2023

Employers are bracing for 2024, fearing they’ll face inflation and soaring healthcare costs while still trying to recruit and retain workers in a tight labor market, a new survey shows. | Employers got something of a break last year from inflation when it comes to healthcare costs because most contracts with providers last three years. A survey by the consulting company Mercer says they won’t be so lucky in 2024.

115

115

Pharmacy Times

MAY 31, 2023

What's bothering the pharmacist?

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MAY 31, 2023

More than half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. The largest proportion of them were based in the UK and the EU, with 71% and 70% recorded respectively in GlobalData’s report Thematic Intelligence: Brexit and the Healthcare Industry 2023 (Figure 1). A Brexit survey conducted previously by GlobalData in 2021 found that the majority (60%) of the respondents had a more neutral sentiment towards Brexi

22

22

Pharmacy Times

MAY 31, 2023

The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate.

FDA 122

FDA 122

Fierce Healthcare

MAY 31, 2023

Despite the increased adoption of digital health tools and telehealth in the past three years, patients and providers see the "digital front door" as still being a less-than-ideal entry point into | More than a quarter of patients believe the payment experience has gotten worse. Four in 10 patients said they’re likely to cancel or postpone care without an accurate cost estimate.

111

111

Pharmaceutical Technology

MAY 31, 2023

XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will receive $250m in upfront and milestone payments. The two companies will use XtalPi’s integrated AI capabilities and robotics platform for the de novo [without consideration of previous instances] design and delivery of drug candidates for an undisclosed target.

Compounding 111

Compounding 111

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

MAY 31, 2023

Hospitals’ year-to-date operations broke even in April, though a rise in bad debt and a dip in volumes suggest the upward momentum will likely be short-lived, healthcare consulting firm Kaufman Hal | Kaufman Hall's latest monthly industry report showed a 0% year-to-date median operating margin across the hospital industry as well as signs of bad debt and charity care beginning to pick up as states begin paring their Medicaid populations.

Hospitals 109

Hospitals 109

Drug Store News

MAY 31, 2023

The gaming phenomenon inspired the limited-edition makeup collection.

105

105

Fierce Healthcare

MAY 31, 2023

BENTONVILLE, Arkansas—Retail giant Walmart will roll out a new program that aims to assist employees of its vision centers in advancing their careers. | Retail giant Walmart will roll out a new program that aims to assist employees of its vision centers in advancing their careers.

104

104

STAT

MAY 31, 2023

The Food and Drug Administration approved a second vaccine to protect older adults against RSV on Wednesday, giving a green light to Pfizer’s Abrysvo for adults 60 and older. Early in May the FDA approved the first ever vaccine against respiratory syncytial virus, or RSV, when it licensed GSK’s Arexvy.

Vaccines 101

Vaccines FDA 101

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

MAY 31, 2023

Sanofi scores in MS with CD40 antibody frexalimab Phil.

98

98

STAT

MAY 31, 2023

The high cost of cancer treatment in the U.S. is literally killing people. “Over a quarter of cancer patients delay medical care , go without care, or make changes in their cancer treatment because of cost,” Ezekiel Emanuel, an oncologist and co-director of the Health Care Transformation Institute at the University of Pennsylvania, wrote in a recent First Opinion essay.

101

101

Drug Store News

MAY 31, 2023

Giant Food plans to limit the number of entrances to stores to create more obstacles for shoplifters and also hire security guards.

98

98

STAT

MAY 31, 2023

A family nurse practitioner in New York City, Jose M. Maria has come to expect overt racism from patients. “I’ve been called the N-word, I’ve been called, you name it,” he said. A triple minority in nursing — Black, Latino, and male — he often gets mistaken for a janitor. More subtle racist behavior has come from supervisors and fellow nurses in past jobs, too — uncomfortable looks in the break room, extra questioning from supervisors over narcoti

100

100

Pharmaceutical Technology

MAY 31, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a new drug application (NDA) for its investigational single-tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) to the US Food and Drug Administration (FDA), to treat pulmonary arterial hypertension (PAH). The company is seeking approval for the combination therapy for the long-term treatment of PAH in adult patients with World Health Organisation functional class II-III.

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies 98

STAT

MAY 31, 2023

As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health, which owns one of the largest PBMs in the country, said the company would find ways to maintain its level of profit if those reforms to things like drug rebates went into effect. “There’s other ways in the economic model that we can adjust to if one of those things changes,” Shawn Guertin, CVS’ chief financial officer, said at an industry conference Wednesday.

Insurance 98

Insurance 98

InCrowd

MAY 31, 2023

Happy Mental Health Awareness Month! But wait… is it really happy? What does mental health awareness truly mean? I’ve always struggled with the idea of dedicating a single month to a specific cause. While it’s important to de-stigmatize mental illness and endeavor to provide mental health organizations with desperately needed funding, I worry that awareness will wane the moment this month ends?

98

98

STAT

MAY 31, 2023

“Hey, I’m sorry to bother you, but I could really use your advice on something.” As fellows in oncology training programs, we’re both accustomed to fielding texts, emails, and calls that start out like the above from family, friends, and acquaintances seeking guidance for themselves or their loved ones after a cancer diagnosis.

98

98

Drug Store News

MAY 31, 2023

​​​​​​​The Walgreens Clinical Trials team brought together industry professionals and community members to talk about the advances and challenges in the clinical trials space.

98

98

STAT

MAY 31, 2023

WASHINGTON — House Republicans are ratcheting up pressure on federal agencies’ pandemic response with an unprecedented move: interrogating a career poxvirus scientist’s infectious disease work. In a letter to federal health officials Tuesday, top Republicans on the Energy and Commerce Committee asked longtime researcher Bernard Moss, who has worked for the National Institute of Allergy and Infectious Diseases for more than four decades, to sit for a videotaped interview abou

98

98

Pharmaceutical Technology

MAY 31, 2023

The Danish CRISPR biotech SNIPR BIOME has released the first glimpse at the safety profile for SNIPR001, a gene therapy intended to target antibiotic resistance. Interim clinical results from a Phase I trial have demonstrated SNIPR001’s safety in healthy volunteers. Additionally, E.Coli was detected in a dose-dependent manner in feces, suggesting the therapy’s proof-of-principle targetin and removing the bacteria, including antibiotic-resistant strains.

Chemotherapy 98

Chemotherapy FDA Communication Immunization 98

Drug Store News

MAY 31, 2023

The retailer has promoted several officers across its Store Support Center and Field teams and appointed a new leader of inventory teams for its consumables business.

98

98

European Pharmaceutical Review

MAY 31, 2023

The novel CRISPR-Cas therapeutic selectively targets antibiotic-resistant E. coli which can cause life-threatening bloodstream infections” Positive interim results from a Phase I trial have demonstrated that the first CRISPR-armed phage microbial gene therapy can reduce Escherichia coli ( E. coli ) levels in the GI tract. “With the combined killing effects of bacteriophages and CRISPR-Cas technology, SNIPR001 has demonstrated the ability to target and eliminate antibiotic-resistant E

98

98

STAT

MAY 31, 2023

Hey there. STAT reporter Andrew Joseph here welcoming you to Wednesday’s edition of Pharmalittle, with Pharmalot himself off for the day. We’re based here in London, so instead of firing up another cup of stimulation, we’re more focused on what post-lunch snack awaits us. As we ponder, we’ll leave you with the latest headlines.

98

98

pharmaphorum

MAY 31, 2023

ASCO 2023 preview: Prioritising the exploration of patient differences to enhance cancer care and research Mike.

98

98